Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- CheckyesterdayChange DetectedRevision metadata updated to v3.5.5, replacing the previous v3.5.4. This reflects a new release version of the page without altering the displayed study details or status.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision label in the metadata was updated from v3.5.3 to v3.5.4. This update indicates an internal versioning change rather than a modification to the trial details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page has been updated to a newer ClinicalTrials.gov revision identifier (v3.5.3), replacing the previous one (v3.5.2) without changing the underlying study information.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.